The group around Du XIANG at Fudan University Cancer Hospital is using the anaplastic lymphoma kinase (ALK) gene as a marker for the early identification of NSLC which support appropriate therapy.
China Bio news release, June 16, 2015
The group around Du XIANG at Fudan University Cancer Hospital is using the anaplastic lymphoma kinase (ALK) gene as a marker for the early identification of NSLC which support appropriate therapy.
China Bio news release, June 16, 2015